IDO1 and PDL1 are immune checkpoints with key roles in immune system regulation. Their relevance stems from their ability to suppress T-cell function. T-cells are vital to the body’s immune response ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Evie, now 19, experienced eight different symptoms in the lead-up to being diagnosed with Hodgkin lymphoma, a type of blood ...

The following is a summary of “Identification of molecular clusters and a risk prognosis model for diffuse large B-cell lymphoma based on lactate metabolism-related genes,” published in the April 2025 ...

The current first-line treatment for peripheral T-cell lymphoma (PTCL) has a typically poor prognosis. Developing a new regimen is urgently needed. This phase I study evaluated the maximum tolerated ...

or death by 37% vs standard therapy in patients ≥ 70 years with diffuse large B-cell lymphoma (DLBCL). Safety profiles were comparable between treatments with similar rates of grade 3-4 adverse ...

The phase I EXCELERIZE dose-escalation study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of REC-3565 for treating R/R B-cell lymphomas in ...

This is particularly promising for patients with B-cell malignancies ... REC-3565 is a mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor designed using Recursion ...

When he was first diagnosed with mantle cell lymphoma in New York in 2005 ... give those patients "a ton of steroids" to treat those symptoms, and that can limit the effectiveness of the treatment ...

These findings suggest this unique cell therapy approach has promise for specific patients with lymphoma, but it may be adapted for more cancer types in the future. "We observed rapid and strong ...

In a strong validation of the company’s clinical trial, Imugene Ltd’s Phase 1b trial for its azer-cel off-the-shelf, allogeneic, CD19 CAR T therapy in relapsed/refractory diffuse large B-cell lymphoma ...